Attention-Deficit/Hyperactivity Disorder Overdiagnosis and Overprescriptions: Medicalization of Distractions

Wood S. Sage J.R. Shuman T. Anagnostaras S.G.

Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Pharmacol Rev. 2014; 66: 193-221https://doi.org/10.1124/pr.112.007054

Introduction to psychoactive substances.

in: Begun A.L. Murray M. The Routledge Handbook of Social Work and Addictive Behaviors. Routledge, 2020: 2

Methylphenidate.

in: StatPearls [Internet]. StatPearls Publishing, 2019Najib J. Wimer D. Zeng J. et al.

Review of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.

J Cent Nerv Syst Dis. 2017; 91179573517728090https://doi.org/10.1177/1179573517728090Visser S.N. Danielson M.L. Bitsko R.H. et al.

Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011.

J Am Acad Child Adolesc Psychiatry. 2014; 53: 34-46.e2https://doi.org/10.1016/j.jaac.2013.09.001Danielson M.L. Bitsko R.H. Ghandour R.M. Holbrook J.R. Kogan M.D. Blumberg S.J.

Prevalence of parent-reported ADHD diagnosis and associated treatment among US children and adolescents, 2016.

J Clin Child Adolesc Psychol. 2018; 47: 199-212https://doi.org/10.1080/15374416.2017.1417860Oehrlein E.M. Burcu M. Safer D.J. Zito J.M.

National Trends in ADHD Diagnosis and Treatment: Comparison of Youth and Adult Office-Based Visits.

Psychiatr Serv. 2016; 67: 964-969Sibley M.H. Rohde L.A. Swanson J.M. et al.

Late-onset ADHD reconsidered with comprehensive repeated assessments between ages 10 and 25.

Am J Psychiatry. 2018; 175: 140-149https://doi.org/10.1176/appi.ajp.2017.17030298

Psychosocial functioning among college students who misuse stimulants versus other drugs.

Addict Behav. 2020; 105: 106290https://doi.org/10.1016/j.addbeh.2020.106290Kariisa M. Scholl L. Wilson N. Seth P. Hoots B.

Drug overdose deaths involving cocaine and psychostimulants with abuse potential—United States, 2003–2017.

MMWR Morb Mortal Wkly Rep. 2019; 68: 388-395

Do prescription stimulants increase the risk of adverse cardiovascular events?: a systematic review.

BMC Cardiovasc Disord. 2012; 12: 41https://doi.org/10.1186/1471-2261-12-41American Psychiatric Association

Diagnostic and Statistical Manual of Mental Disorders.

Fifth Edition. American Psychiatric Association, 2013

Changes in the definition of ADHD in DSM-5: subtle but important.

Neuropsychiatry (London). 2013; 3: 455-458https://doi.org/10.2217/npy.13.59

Drug Enforcement Administration, Diversion Control Division. Automation of Reports andConsolidated Orders System (ARCOS).

National Survey on Drug Use and Health

2018 NSDUH detailed tables.

Bossaer J.B. Gray J.A. Miller S.E. Enck G. Gaddipati V.C. Enck R.E.

The use and misuse of prescription stimulants as “cognitive enhancers” by students at one academic health sciences center.

Acad Med. 2013; 88: 967-971https://doi.org/10.1097/ACM.0b013e318294fc7bPaulozzi L.J. Strickler G.K. Kreiner P.W. Koris C.M.

Controlled substance prescribing patterns—prescription behavior surveillance system, eight states, 2013.

MMWR Surveill Summ. 2015; 64: 1-14US Department of Justice, Drug Enforcement Administration, Diversion Control Division

ARCOS retail drug summary reports.

Piper B.J. Ogden C.L. Simoyan O.M. et al.

Trends in use of prescription stimulants in the United States and territories, 2006 to 2016.

PLoS One. 2018; 13e0206100Chen L.-Y. Crum R.M. Strain E.C. Alexander G.C. Kaufmann C. Mojtabai R.

Prescriptions, nonmedical use, and emergency department visits involving prescription stimulants.

J Clin Psychiatry. 2016; 77: e297-e304https://doi.org/10.4088/JCP.14m09291Polanczyk G. De Lima M.S. Horta B.L. Biederman J. Rohde L.A.

The worldwide prevalence of ADHD: a systematic review and metaregression analysis.

Am J Psychiatry. 2007; 164: 942-948https://doi.org/10.1176/ajp.2007.164.6.942Kessler R.C. Adler L. Barkley R. et al.

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication.

Am J Psychiatry. 2006; 163: 716-723https://doi.org/10.1176/ajp.2006.163.4.716Moffitt T.E. Houts R. Asherson P. et al.

Is adult ADHD a childhood-onset neurodevelopmental disorder? evidence from a four-decade longitudinal cohort study.

Am J Psychiatry. 2015; 172: 967-977https://doi.org/10.1176/appi.ajp.2015.14101266

Hyperactive around the world? the history of ADHD in global perspective.

Soc Hist Med. 2017; 30: 767-787https://doi.org/10.1093/shm/hkw127

Why does the worldwide prevalence of childhood attention deficit hyperactivity disorder matter?.

Am J Psychiatry. 2007; 164: 856-858https://doi.org/10.1176/appi.ajp.164.6.856Matte B. Anselmi L. Salum G.A. et al.

ADHD in DSM-5: a field trial in a large, representative sample of 18-to 19-year-old adults.

Psychol Med. 2015; 45: 361-373https://doi.org/10.1017/S0033291714001470

DSM-5 further inflates attention deficit hyperactivity disorder.

J Nerv Ment Dis. 2012; 200: 486-488https://doi.org/10.1097/NMD.0b013e318257c4b6Hudson J.L. Miller G.E. Kirby J.B.

Explaining racial and ethnic differences in children's use of stimulant medications.

Med Care. 2007; 45: 1068-1075https://doi.org/10.1097/MLR.0b013e31806728faSchneider H. Eisenberg D.

Who receives a diagnosis of attention-deficit/ hyperactivity disorder in the United States elementary school population?.

Pediatrics. 2006; 117: e601-e609https://doi.org/10.1542/peds.2005-1308Fulton B.D. Scheffler R.M. Hinshaw S.P.

State variation in increased ADHD prevalence: links to NCLB school accountability and state medication laws.

Psychiatr Serv. 2015; 66: 1074-1082https://doi.org/10.1176/appi.ps.201400145

留言 (0)

沒有登入
gif